<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>29(12)</volume><submitter>Qiu W</submitter><funding>Shandong Province Natural Science Foundation</funding><funding>National Natural Science Foundation of China</funding><funding>Shandong University</funding><funding>Taishan Scholar Foundation of Shandong Province</funding><pubmed_abstract>Glioma is a heterogeneous cellular environment in which immune cells play critical roles in tumor progression. Myeloid-derived suppressor cells (MDSCs) contribute to the formation of the immunosuppressive microenvironment of glioma; however, how glioma cells interact with MDSCs and how this interaction affects the function of other immune cells are unclear. Glioma cells can systemically communicate with immune cells via the secretion of exosomes, which contain microRNAs (miRNAs). Leveraging miRNA sequencing of exosomes, we identified enrichment of miR-1246 in glioma-derived exosomes and exosomes isolated from the cerebrospinal fluid (CSF) of glioma patients. We demonstrated that miR-1246 drives the differentiation and activation of MDSCs in a dual specificity phosphatase 3 (DUSP3)/extracel</pubmed_abstract><journal>Molecular therapy : the journal of the American Society of Gene Therapy</journal><pagination>3449-3464</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8636176</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Exosomal miR-1246 from glioma patient body fluids drives the differentiation and activation of myeloid-derived suppressor cells.</pubmed_title><pmcid>PMC8636176</pmcid><pubmed_authors>Li G</pubmed_authors><pubmed_authors>Pan Z</pubmed_authors><pubmed_authors>Guo X</pubmed_authors><pubmed_authors>Deng L</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Guo Q</pubmed_authors><pubmed_authors>Qiu W</pubmed_authors><pubmed_authors>Zhao S</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Zhao R</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Qi Y</pubmed_authors><pubmed_authors>Li B</pubmed_authors><pubmed_authors>Xue H</pubmed_authors><pubmed_authors>Qian M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Exosomal miR-1246 from glioma patient body fluids drives the differentiation and activation of myeloid-derived suppressor cells.</name><description>Glioma is a heterogeneous cellular environment in which immune cells play critical roles in tumor progression. Myeloid-derived suppressor cells (MDSCs) contribute to the formation of the immunosuppressive microenvironment of glioma; however, how glioma cells interact with MDSCs and how this interaction affects the function of other immune cells are unclear. Glioma cells can systemically communicate with immune cells via the secretion of exosomes, which contain microRNAs (miRNAs). Leveraging miRNA sequencing of exosomes, we identified enrichment of miR-1246 in glioma-derived exosomes and exosomes isolated from the cerebrospinal fluid (CSF) of glioma patients. We demonstrated that miR-1246 drives the differentiation and activation of MDSCs in a dual specificity phosphatase 3 (DUSP3)/extracel</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-04-26T09:46:18.665Z</modification><creation>2025-04-06T13:08:10.609Z</creation></dates><accession>S-EPMC8636176</accession><cross_references><pubmed>34217892</pubmed><doi>10.1016/j.ymthe.2021.06.023</doi></cross_references></HashMap>